Customer-centric and science-driven CDMO supporting biopharma companies from R&D to market
A continuum of services to suit every step of your project
Customer-centric CDMO:
Discover our flexible manufacturing solutions for biopharma companies
Biologics CDMO
Expert process development and manufacturing services for a diversity of biotherapeutics.
Bioconjugates (ADC)
Flexible development and GMP manufacturing capacities for antibody-drug conjugates.
Nanodrugs CDMO
Integrated services for challenging API from formulation and development to GMP manufacturing.
Biologics CDMO: How we support your biopharmaceuticals
We’ve helped our customers develop and manufacture innovative therapies for more than 20 years.
Our CDMO expertise spans all stages of biotherapetics development from R&D to commercial production
Years as a CDMO
Years' expertise in aseptic filling
Clients served worldwide
Protein programmes managed
Biologics CDMO - a continuum of services
Depending on you project, our production units will collaborate to offer you the best quality of service and work hand in hand from the start to move your project all the way from discovery lab bench to clinic.
Discover the expertise field of each production unit!
Saint-Julien
GTP Biologics
Toulouse
GTP Nano
Labège
GTP Tech
ISSOIRE
GTP Immuno
From our blog:Our biologics CDMO experience
Use of an innovative viral inactivation method for a complex recombinant protein to be used as vaccine for COVID-19
Case study: Use of an innovative viral inactivation method for a complex recombinant protein to be used as vaccine for COVID-19 When developping a process for our clients, we always keep in mind...
Antibody-Drug Conjugates (ADC) and their potential therapeutic applications
In the dynamic landscape of therapeutic development, antibody-drug conjugates (ADCs) have emerged as a ground-breaking class of biotherapeutics. ADCs are the result of a powerful fusion of...
A review of the therapeutic use of monoclonal antibodies
Monoclonal antibodies (mAbs) have become a dominant product class within the biopharmaceutical market. To date, therapeutic antibodies have been used to treat a plethora of indications including...